SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001387131-20-007002
Filing Date
2020-08-04
Accepted
2020-08-04 09:06:05
Documents
18
Period of Report
2020-08-03
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT tnxp-8k_080320.htm 8-K 19731
2 PRESS RELEASE ex99-01.htm EX-99.01 10823
3 POSTER PRESENTATION ex99-02.htm EX-99.02 23984
4 PRESS RELEASE ex99-03.htm EX-99.03 12337
5 GRAPHIC ex9902001.jpg GRAPHIC 113315
6 GRAPHIC ex9902002.jpg GRAPHIC 78653
7 GRAPHIC ex9902003.jpg GRAPHIC 100954
8 GRAPHIC ex9902004.jpg GRAPHIC 140730
9 GRAPHIC ex9902005.jpg GRAPHIC 144427
10 GRAPHIC ex9902006.jpg GRAPHIC 144960
11 GRAPHIC ex9902007.jpg GRAPHIC 131770
12 GRAPHIC ex9902008.jpg GRAPHIC 138202
13 GRAPHIC ex9902009.jpg GRAPHIC 78097
14 GRAPHIC ex9902010.jpg GRAPHIC 120082
15 GRAPHIC ex9902011.jpg GRAPHIC 111410
16 GRAPHIC ex9902012.jpg GRAPHIC 115885
17 GRAPHIC ex9902013.jpg GRAPHIC 123824
18 GRAPHIC ex9902014.jpg GRAPHIC 128419
  Complete submission text file 0001387131-20-007002.txt   2371136
Mailing Address 509 MADISON AVE. - SUITE 1608 NEW YORK NY 10022
Business Address 509 MADISON AVE. - SUITE 1608 NEW YORK NY 10022 1-800-849-7894
Tonix Pharmaceuticals Holding Corp. (Filer) CIK: 0001430306 (see all company filings)

IRS No.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36019 | Film No.: 201071126
SIC: 2834 Pharmaceutical Preparations